Literature DB >> 7825447

The fluctuations of neuron-specific enolase (NSE) levels of cerebrospinal fluid during bacterial meningitis: the relationship between the fluctuations of NSE levels and neurological complications or outcome.

S Inoue1, H Takahashi, K Kaneko.   

Abstract

Neuron-specific enolase (NSE) is one of the glycolytic enzymes distributed exclusively in neurons. It was measured serially in the cerebrospinal fluid (CSF) of 10 children with bacterial meningitis during the illness using radio-immunoassay. The relationship between CSF-NSE levels and neurological complications or outcome was examined. CSF-NSE levels were significantly higher in the patients with bacterial meningitis than in the patients with the other central nervous system (CNS) infectious diseases, suggesting that CNS damage in those patients with bacterial meningitis was exacerbated. As CSF-NSE levels increased to above 25 ng/mL in the acute phase, all patients except one had subdural effusion. In those patients whose CSF-NSE level rose again during the illness, CNS complications or sequelae occurred. CSF-NSE may be a useful prognostic factor for predicting CNS damage in childhood bacterial meningitis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7825447     DOI: 10.1111/j.1442-200x.1994.tb03230.x

Source DB:  PubMed          Journal:  Acta Paediatr Jpn        ISSN: 0374-5600


  8 in total

1.  Gemifloxacin is effective in experimental pneumococcal meningitis.

Authors:  A Smirnov; A Wellmer; J Gerber; K Maier; S Henne; R Nau
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

Review 2.  Modulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningitis.

Authors:  Roland Nau; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

3.  Beta2-microglobulin concentrations in cerebrospinal fluid correlate with neuroimaging findings in newborns with symptomatic congenital cytomegalovirus infection.

Authors:  Ana Alarcon; Alfredo Garcia-Alix; Fernando Cabañas; Angel Hernanz; Dora Pascual-Salcedo; Ana Martin-Ancel; Marta Cabrera; Alfredo Tagarro; Jose Quero
Journal:  Eur J Pediatr       Date:  2006-05-12       Impact factor: 3.183

4.  Moxifloxacin in the therapy of experimental pneumococcal meningitis.

Authors:  H Schmidt; A Dalhoff; K Stuertz; F Trostdorf; V Chen; O Schneider; C Kohlsdorfer; W Brück; R Nau
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

Review 5.  Clinical significance of serum biomarkers in pediatric solid mediastinal and abdominal tumors.

Authors:  John A Sandoval; Linda H Malkas; Robert J Hickey
Journal:  Int J Mol Sci       Date:  2012-01-20       Impact factor: 6.208

6.  Neuron-specific enolase as a novel biomarker reflecting tuberculosis activity and treatment response.

Authors:  Sung-Jin Nam; Jee-Yeong Jeong; Tae-Won Jang; Mann-Hong Jung; Bong-Kwon Chun; Hee-Jae Cha; Chul-Ho Oak
Journal:  Korean J Intern Med       Date:  2016-06-03       Impact factor: 2.884

7.  Serum and cerebrospinal fluid neuron-specific enolase for diagnosis of tuberculous meningitis.

Authors:  Tae-Jin Song; Young-Chul Choi; Kyung-Yul Lee; Won-Joo Kim
Journal:  Yonsei Med J       Date:  2012-11-01       Impact factor: 2.759

8.  Serum enolase-2, high-sensitivity C-reactive protein, and serum cholesterol in smear-positive drug-naïve pulmonary tuberculosis.

Authors:  Suhail Ahmed Almani; Tariq Zaffar Shaikh; Haji Khan Khoharo; Ikramuddin Ujjan
Journal:  J Res Med Sci       Date:  2017-04-26       Impact factor: 1.852

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.